The EMA has endorsed Aquipta, an oral CGRP receptor antagonist, after it showed superior pain relief vs placebo in treating migraine attacks in adults.

Eptinezumab plus education reduces monthly migraine days in adults with chronic migraine and medication-overuse headache.

Results provide evidence needed to challenge the step-through reimbursement requirements that have restricted Qulipta's ...

Discover how "gepants" (CGRP inhibitors) are changing migraine care. Learn about their use for acute relief and prevention, ...

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...

Migraine sufferers taking weight loss and diabetes medication are less likely to need emergency care or medication, a study has suggested. GLP-1 drugs, such as Ozempic and Wegovy, are prescribed to ...

Next-generation weight loss drugs may do more than shrink your waistline. A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines ...

(WXYZ) — Migraines can be debilitating, but the symptoms that show up before the headache hits can be just as tough. Now, a new study shows that acting fast with ...

The high cost of prescription drugs is a hot topic in the U.S., a factor likely on the minds of Amgen executives in setting the price of a new treatment for migraine headaches. The drug, to be sold ...

A new class of migraine drugs called gepants is transforming care by offering both acute and preventive treatment in one medication, with fewer side effects and no cardiovascular risks. These CGRP ...

Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...